Epidemiological studies have shown that missense mutations of the Apo D gene are associated with elevated plasma triglycerides24, 25 and a Taq1 polymorphism with the development of obesity, insulin resistance and T2D26, 27. The gene discussed is APOD; the disease is Insulin resistance.